Current Research Studies
A Phase 1/2, Multicenter, Open-Label Study to Investigate the Safety, Tolerability, and Efficacy of a Single Intravenous Dose of SGT-003 in Ambulant Males with Duchenne Muscular Dystrophy
INSPIRE DUCHENNE
What is the goal of the study?
A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy
Who can participate in the study?
Please contact the study team listed below to learn more.